Key result
The COVID-19 pandemic has led to a higher pediatric obesity rate, increasing the risk of metabolic alterations, cardiovascular disease, and COVID-19 severity.
Why the study?
Pediatric obesity increased exponentially globally and during the COVID-19 pandemic, leading to metabolic alterations and complications, making timely diagnosis and treatment important to reduce mortality.
Obesity in children and adolescents has increased during the COVID-19 pandemic, leading to various metabolic and cardiovascular complications that require timely diagnosis and treatment.
Hypothesis-generating for post-pandemic pediatric cardiometabolic risks; prospective studies needed before changing practice.
Background: Obesity in children and adolescents has increased exponentially around the world. Furthermore, the COVID-19 pandemic has led to a higher pediatric obesity rate. The excess adipose tissue generates a dysregulation of adiponectin, ghrelin, and leptin, among others. Metabolic alterations can develop cardiovascular disease, dyslipidemias, arterial hypertension, type 2 diabetes mellitus, nonalcoholic fatty liver disease, sleep disorders, and higher risk of COVID-19 severity. Obesity has different therapeutic approaches such as behavioral weight loss programs, pharmacologic treatments, and surgical procedures. Therefore, timely diagnosis and treatment are important to decrease the mortality in obesity among pediatric population.
No takes yet. Share an insight, caveat, or question.
Concepción‐Zavaleta et al. (2021) conducted a review in Obesity in children and adolescents. Obesity during COVID-19 pandemic was evaluated. The COVID-19 pandemic has led to a higher pediatric obesity rate, increasing the risk of metabolic alterations, cardiovascular disease, and COVID-19 severity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: